Personalised ultraviolet B treatment of psoriasis

Not Applicable

Suspended

• Conditions: Psoriasis; Skin and Connective Tissue Diseases

• Registration Number: ISRCTN44977207
• Lead Sponsor: ewcastle upon Tyne Hospitals NHS Foundation Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-05-13
• Last Update Posted: 25 May 2020
• Study Completion: 2021-10-31

Recruitment & Eligibility

• Status: Suspended
• Sex: All
• Target Recruitment: 135

Inclusion Criteria

1. Aged 18 years or older (no upper age limit)
2. Able to speak English
3. Able to provide informed consent
4. Has chronic plaque psoriasis
5. Prescribed NbUVB phototherapy
6. Able and willing to attend the phototherapy department regularly

Exclusion Criteria

1. Able to control their psoriasis or already controlled by topical therapy
2. Pregnant
3. Have had significant sun exposure, sun-bed use or previous NbUVB within the last month or be planning significant sun exposure or sun-bed use in the next month
4. Have previously taken, in the last three months any of the following: methotrexate, azathioprine, ciclosporin, biological therapy or systemic steroids for treatment of psoriasis
5. Have previously taken, in the last month, any oral photosensitising medications, including: thiazide diuretics, antibiotics such as tetracyclines and quinolones, non-steroidal anti-inflammatory drugs, phenothiazines, retinoids, sulphonylureas, quinine and St John’s Wort
6. Also suffer from diseases where phototherapeutic treatment is contraindicated: xeroderma pigmentosum, lupus erythematosus

Study & Design

• Study Type: Interventional
• Study Design: Not specified